While higher serum chemerin concentrations are generally associated with pro-cancer effects in NSCLC, many findings point to a role of localized chemerin in promoting anti-cancer effects via the recruitment of NK cells to the tumor microenvironment [120,121]. The gene discussed is RARRES2; the disease is neoplasm.